Genmab (GMAB) cash on hand

Cash · fiscal 2025
$1.72B

Genmab (GMAB) held cash of $1.72B at the end of fiscal 2025 (December 31, 2025). That is 41.9% lower than the $2.95B of fiscal 2024. Figures as of 18 Nov 2026, 05:36 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
$1.72B
Change on fiscal 2024
−41.9%
Highest on record
$4.17Bfiscal 2023
Lowest on record
$1.72Bfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Genmab cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $4.17B in fiscal 2023 and the lowest $1.72B in fiscal 2025.

History · 4 fiscal years

Cash by fiscal year

Genmab cash on hand, year by year

Genmab (GMAB) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$1.72B 41.9% down
2024$2.95B 29.2% down
2023$4.17B 29.8% up
2022$3.21B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Genmab and comparable companies
CompanyCashFiscal year
Mettler-Toledo International MTD$66.89M2025
Centene CNC$20.32B2025
Genmab GMAB$1.72B2025
Illumina ILMN$1.63B2025
ResMed RMD$1.47B2026
Zoetis ZTS$2.31B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMAB

Genmab, figure by figure

Genmab (GMAB) overview: price, valuation and scorecardAll health care companies by market value

Genmab cash on hand: questions and answers

How much cash does Genmab have?

Genmab (GMAB) held cash of $1.72B at the end of fiscal 2025 (December 31, 2025). That is 41.9% lower than the $2.95B of fiscal 2024.

What are the highest and lowest cash figures on record for Genmab?

Across the 4 fiscal years on record (2022–2025), the highest was $4.17B in fiscal 2023 and the lowest $1.72B in fiscal 2025.

How is Genmab's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Genmab (GMAB) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/GMAB/cash

Underlying data: Yahoo Finance.